My Companies
Notification
Account
Subsidiary Noumed Pharmaceuticals signed a 7.5-year exclusive OTC supply deal with Australia’s top pharmacy network, worth AUD 202M (₹1,300Cr).
Sai Parenterals Renews AUD 30 Million Australian OTC Supply Agreement
Sai Parenterals Renews ₹204 Crore Australian OTC Supply Agreement
Sai Parenterals Redirects ₹83.83 Crore IPO Proceeds To Saicriti Acquisition
Sai Parenterals Approves ₹101.86 Crore IPO Proceeds Shift Into Two Pharma Acquisitions